Allkem (OROCF) and Livent Corporation (NYSE: LTHM) have announced the receipt of all necessary regulatory approvals for their impending merger, slated for completion on January 4, 2024. This merger of equals has cleared antitrust hurdles in multiple jurisdictions, including Canada, China, Japan, South Korea, and the U.S., alongside investment screenings in Australia, the U.K., and the U.S.

The successful closure of the merger hinges on the approval of shareholders from both companies and the Australian Court’s sanction of the Scheme. Livent, a lithium production veteran of nearly 80 years, boasts a diverse product portfolio and operates across four countries with a workforce of around 1,350.

This merger is expected to create a powerhouse in the lithium industry, with the combined entity poised to capitalize on the surging demand for lithium, essential for green energy and modern technologies. However, the forward-looking statements in this announcement are subject to various risks and uncertainties, and actual results may differ materially.

Investors are advised to read the proxy statement/prospectus and other relevant documents filed with the SEC carefully for a more comprehensive understanding of the merger and its implications.

Company Website: https://www.allkem.co

Source

Disclaimer:
The content presented on this page has not been manually verified by our team. While we strive to ensure accuracy, we cannot guarantee the validity, completeness, or timeliness of the information provided. Always consult with appropriate professionals or sources before making any decisions based on this content.

Click here for more Company News